Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Coproporphyria 1Aberrant Crypt Foci 1

Interventions

Oxaliplatin 112Fluorouracil 104Leucovorin 91Irinotecan 91Capecitabine 59Bevacizumab 58Cetuximab 46Folfox protocol 28Colonoscopy 24Panitumumab 19Chemotherapy, Adjuvant 19Blood Specimen Collection 19Drug Therapy 18Nivolumab 17Magnetic Resonance Spectroscopy 17Radiotherapy 16Exercise 16Early Intervention, Educational 16Surveys and Questionnaires 15Laparoscopy 15Surgical Procedures, Operative 13Floxuridine 13Biopsy 13trifluridine tipiracil drug combination 12pembrolizumab 12XELOX 12Neoadjuvant Therapy 11Methods 11Immunohistochemistry 11Celecoxib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Colonic Neoplasms × Sulindac × Clear all
NCT00062023 2012-07-30

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
12 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00003365 2011-01-27

Sulindac and Plant Compounds in Preventing Colon Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡